Substance abuse

There is substantial clinical need to recognize the individuals who need care for cognitive issues that go beyond normal aging. These problems are noticeable, but clinicians have lacked a reliable diagnosis by which to assess symptoms the most proper treatment or services. Recent studies suggest that identifying mild neurocognitive disorders in the early stages itself may allow interventions to be more effective. Early intervention efforts may enable the use of treatments that are ineffective at more severe levels of impairment and may prevent or slow progression. Researchers will analyze how well the new diagnostic criteria address the depressive symptoms, as well as potential therapies like educational or brain stimulation.

  • lung cancer 
  • emphysema
  • Heart stroke

Related Conference of Substance abuse

March 18-19, 2024

34th Euro Congress on Psychiatrists and Psychologists

Zurich, Switzerland
April 11-12, 2024

4th Annual Congress on Mental Health

Amsterdam, Netherlands
May 23-24, 2024

41th Global Psychiatry and Mental Health Conference

Zurich, Switzerland
May 27-28, 2024

6th European Autism Congress

Paris, France
July 15-16, 2024

6th International Congress on Mental Health

Amsterdam, Netherlands
September 09-10, 2024

5th Annual Congress on Psychiatry

London, UK

Substance abuse Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in